Alpha-asarone Improves Cognitive Function of APP/PS1 Mice and Reducing Aβ42, P-tau and Neuroinflammation, and Promoting Neuron Survival in the Hippocampus
[Display omitted] •Alpha-asarone improves the cognitive function of APP/PS1 transgenic mice.•Alpha-asarone reduced Aβ42 and p-tau protein levels in the hippocampus.•Alpha-asarone reduced the brain GFAP expression and alleviated neuroinflammation.•Alpha-asarone decreased autophagosomes and promoted h...
Gespeichert in:
Veröffentlicht in: | Neuroscience 2021-03, Vol.458, p.141-152 |
---|---|
Hauptverfasser: | , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | [Display omitted]
•Alpha-asarone improves the cognitive function of APP/PS1 transgenic mice.•Alpha-asarone reduced Aβ42 and p-tau protein levels in the hippocampus.•Alpha-asarone reduced the brain GFAP expression and alleviated neuroinflammation.•Alpha-asarone decreased autophagosomes and promoted hippocampal neuron survival.•Alpha-asarone might be a promising drug candidate for the treatment of AD.
Alzheimer’s disease (AD) is a progressive neurodegenerative disease most often characterized by memory impairment and cognitive decline. Alpha-asarone has been reported to have the potential to treat AD. Our previous studies have found that alpha-asarone improves aged rats’ cognitive function by alleviating neuronal excitotoxicity via type A gamma-aminobutyric acid (GABA) receptors. GABA level’s change, neuroinflammation, and dysfunctional autophagy are found to be associated with AD. However, the effect of alpha-asarone on cognitive function of APP/PS1 transgenic mice and its underlying mechanism in terms of aggregation of amyloid-β42 (Aβ42) and phosphorylated tau (p-tau), glutamic acid decarboxylase (GAD) level, neuroinflammation, and autophagy are unclear. Accordingly, we attempted to explore whether alpha-asarone improves AD mice’s cognitive function and alleviates pathological symptoms by regulating GAD level, inhibiting neuroinflammation, or restore autophagy. We found that alpha-asarone enhanced spatial learning memory and decreased Aβ42 and p-tau levels without influencing the GAD level in APP/PS1 transgenic mice. Also, it decreased the GFAP expression and reduced pro-inflammatory cytokines levels, thus alleviating neuroinflammation. Furthermore, alpha-asarone decreased the excess number of autophagosomes and promoted hippocampal neurons’ survival. In conclusion, the results confirmed the therapeutic effect of alpha-asarone on AD-related astrogliosis, dysfunctional autophagy, and neuronal damage, which indicates its great potential to treat AD. |
---|---|
ISSN: | 0306-4522 1873-7544 |
DOI: | 10.1016/j.neuroscience.2020.12.026 |